Fund managers are buying these ASX shares

Fund managers have been loading up on these ASX shares…

| More on:
Image of fund managers on laptops with share price chart overlaid

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I like to keep an eye on substantial shareholder notices. This is because these notices give you an idea of which shares large investors, asset managers, and investment funds are buying or selling.

Two notices that have caught my eye are summarised below. Here's what this fund manager has been buying:

Mach7 Technologies Ltd (ASX: M7T)

A change of interests of substantial holder notice reveals that Clime Investment Management Limited (ASX: CIW) has taken advantage of weakness in the Mach7 share price to top up its position.

The notice reveals that Clime has picked up ~2.7 million shares in the enterprise image management systems provider since 6 May. This has increased its stake to a total of ~21.79 million shares, which represents a 9.22% stake in the company.

Clime was paying between $1.00 and $1.15 for the shares. So, with the Mach7 share price currently fetching $1.03, investors are able to buy in at around the same levels.

One broker that would approve of these purchases is Morgans. It currently has an add rating and $1.68 price target on its shares.

Straker Translations Ltd (ASX: STG)

Another change of interests of substantial holder notice reveals that Clime has been increasing its position in this translation technology company.

According to the notice, the fund manager has bought over 2 million shares on-market since the end of last month. This has lifted its holding in Straker to ~5.4 million shares, which represents an 8.4% stake in the company.

The release explains that Clime paid between $1.90 and $2.35 for the shares, with the most recent purchases taking place on Tuesday. The latter price is just a touch under the Straker record high of $2.45. This appears to be an indication that the fund manager believes the company is going places.

So, with the Straker share price pulling back to $2.00 today, this could be an opportunity for investors to buy in at an attractive price. Ord Minnett certainly sees it that way. Last week the broker put a buy rating and $2.46 price target on its shares.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended MACH7 FPO. The Motley Fool Australia has recommended MACH7 FPO and Straker Translations. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »